1. Recent Funding
2. Investors
3. GSK

GSK has backed 1 company on Recent Funding, 1 in the last 12 months; its most recent deal is LifeMine Therapeutics (2026-08-06).

What GSK invests in

• Health and bio · 1 · 100%

How GSK invests

Share is of the 2 rounds on Recent Funding that name GSK. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with GSK	Total raised	Latest raise
LLifeMine Therapeutics Health and bio	Aug 6, 2026 Series b+ · $188M	$543M	Aug 6, 2026 Series b+

Most frequent co-investors

• AARCH Venture Partners2 shared rounds · last Aug 6, 2026
• BBezos Expeditions1 shared round · last Aug 6, 2026
• GGates Frontier1 shared round · last Aug 6, 2026
• MMilky Way Investments1 shared round · last Aug 6, 2026
• RRA Capital Management1 shared round · last Aug 6, 2026
• GGV1 shared round · last Mar 23, 2022
• FFidelity Management & Research Company1 shared round · last Mar 23, 2022
• BBlue Pool Capital1 shared round · last Mar 23, 2022
• IInvus1 shared round · last Mar 23, 2022
• MMRL Ventures Fund1 shared round · last Mar 23, 2022
• 33W Partners Capital1 shared round · last Mar 23, 2022

Portfolio companies are the companies on Recent Funding with a round that lists GSK, which is a subset of its real portfolio. API: /api/v1/investors/gsk. All investors.